Recombinant human granulocyte– colony stimulating factor in women with unexplained recurrent pregnancy losses: a randomized clinical trial

Autor: Eapen, A, Joing, M, Kwon, P, Tong, J, Maneta, E, De Santo, C, Mussai, F, Lissauer, D, Carter, D, Ahmed, A, Bass, C, Benderatik, R, Bhattacharya, R, Cheong, Y, Dawood, F, Granne, I, Gupta, P, Horne, A, Manda, P, Mohiyiddeen, L, Moore, J, Quenby, S, Rai, R, Shillito, J, Stewart, J, Truchanowicz, E, Dwyer, L, Small, R, Sharpe, L, Smith, A, Coomarasamy, A, Grp, RESPONSE Study

Publikováno v: Human Reproduction (Oxford, England)
Eapen, A, Joing, M, Kwon, P, Tong, J, Maneta, E, De Santo, C, Mussai, F, Lissauer, D, Carter, D 2019, ' Recombinant human granulocyte-colony stimulating factor in women with unexplained recurrent pregnancy losses : A randomized clinical trial ', Human Reproduction, vol. 34, no. 3, pp. 424-432 . https://doi.org/10.1093/humrep/dey393
HUMAN REPRODUCTION

Study question Does administration of recombinant human granulocyte colony stimulating factor (rhG-CSF) in the first trimester improve pregnancy outcomes, among women with a history of unexplained recurrent pregnancy loss? Summary answer rhG-CSF admi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f28be5dbc70a779e2f322e57cd04257a
http://europepmc.org/articles/PMC6389865

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Cytotoxicity of the anti-CD22 immunotoxin HA22 (CAT-8015) against paediatric acute lymphoblastic leukaemia

Autor: Mussai, F, Campana, D, Bhojwani, D, Stetler-Stevenson, M, Steinberg, S, Wayne, A, Pastan, I

Publikováno v: British journal of haematology. 150(3)

Acute lymphoblastic leukaemia (ALL) remains the most frequent cause of cancer-related mortality in paediatrics and outcome is poor for patients who have high-risk ALL or relapse. HA22 (CAT-8015) is an immunotoxin composed of an anti-CD22 variable fra

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::0bd219b3495571b01cc2d170839e37b8
http://ora.ox.ac.uk/objects/uuid:8be40883-a095-471b-afa3-021ce0215d2f